Cargando…

Current advancements and future perspectives of long noncoding RNAs in lipid metabolism and signaling

BACKGROUND: The investigation of lncRNAs has provided a novel perspective for elucidating mechanisms underlying diverse physiological and pathological processes. Compelling evidence has revealed an intrinsic link between lncRNAs and lipid metabolism, demonstrating that lncRNAs-induced disruption of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Duan, Jiufei, Huang, Zhao, Nice, Edouard C., Xie, Na, Chen, Mingqing, Huang, Canhua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10248733/ https://www.ncbi.nlm.nih.gov/pubmed/35973552 http://dx.doi.org/10.1016/j.jare.2022.08.007

Ejemplares similares

Elesclomol induces copper‐dependent ferroptosis in colorectal cancer cells via degradation of ATP7A
por: Gao, Wei, et al.
Publicado: (2021)

Targeting Glucose Metabolism Enzymes in Cancer Treatment: Current and Emerging Strategies
por: Zhang, Yi, et al.
Publicado: (2022)

Long Noncoding RNAs in Diffuse Large B-Cell Lymphoma: Current Advances and Perspectives
por: Huang, Xianbo, et al.
Publicado: (2020)

The role of noncoding RNAs in cancer lipid metabolism
por: Wang, Ye, et al.
Publicado: (2022)

Revisiting cancer hallmarks: insights from the interplay between oxidative stress and non-coding RNAs
por: Zhou, Li, et al.
Publicado: (2020)

The role of long noncoding RNAs in hepatocellular carcinoma
por: Huang, Zhao, et al.
Publicado: (2020)

The promising role of noncoding RNAs in cancer-associated fibroblasts: an overview of current status and future perspectives
por: Fang, Zengli, et al.
Publicado: (2020)

Managing therapeutic resistance in breast cancer: from the lncRNAs perspective
por: Peng, Liyuan, et al.
Publicado: (2020)

Overcoming cancer therapeutic bottleneck by drug repurposing
por: Zhang, Zhe, et al.
Publicado: (2020)

Long Noncoding RNAs: Novel Important Players in Adipocyte Lipid Metabolism and Derivative Diseases
por: Zhang, Bin, et al.
Publicado: (2021)

Cancer drug resistance: redox resetting renders a way
por: Liu, Yuan, et al.
Publicado: (2016)

Repurposing Oxiconazole against Colorectal Cancer via PRDX2-mediated Autophagy Arrest
por: Shi, Jinyu, et al.
Publicado: (2022)

Noncoding RNAs related to the hedgehog pathway in cancer: clinical implications and future perspectives
por: Song, Jia, et al.
Publicado: (2022)

The Multifaceted Role of Flavonoids in Cancer Therapy: Leveraging Autophagy with a Double-Edged Sword
por: Zhang, Zhe, et al.
Publicado: (2021)

A cellular thermal shift assay for detecting amino acid sites involved in drug target engagement
por: Peng, Liyuan, et al.
Publicado: (2022)

Role of noncoding RNAs in liver fibrosis
por: Li, Qing-Yuan, et al.
Publicado: (2023)

Redox Control of the Dormant Cancer Cell Life Cycle
por: Li, Bowen, et al.
Publicado: (2021)

Circadian rhythms and cancers: the intrinsic links and therapeutic potentials
por: Zhou, Li, et al.
Publicado: (2022)

The crosstalk between reactive oxygen species and noncoding RNAs: from cancer code to drug role
por: Zuo, Jing, et al.
Publicado: (2022)

Enhancing the therapeutic efficacy of nanoparticles for cancer treatment using versatile targeted strategies
por: Tian, Hailong, et al.
Publicado: (2022)

Lipid nanoceuticals: Current status and future perspective
por: Narang, Jasjeet Kaur
Publicado: (2014)

Circular RNAs in Lung Cancer: Recent Advances and Future Perspectives
por: Chen, Huan-Huan, et al.
Publicado: (2021)

Long noncoding RNAs in lipid metabolism: literature review and conservation analysis across species
por: Muret, Kevin, et al.
Publicado: (2019)

Redox homeostasis: the linchpin in stem cell self-renewal and differentiation
por: Wang, Kui, et al.
Publicado: (2013)

Redox regulation in tumor cell epithelial–mesenchymal transition: molecular basis and therapeutic strategy
por: Jiang, Jingwen, et al.
Publicado: (2017)

Proteomics, Personalized Medicine and Cancer
por: Su, Miao, et al.
Publicado: (2021)

Mesenchymal Stem Cell-Derived Exosomal Noncoding RNAs as Alternative Treatments for Myocardial Ischemia-Reperfusion Injury: Current Status and Future Perspectives
por: Chang, Chen, et al.
Publicado: (2023)

Progress and prospects of long noncoding RNAs in lipid homeostasis
por: Chen, Zheng
Publicado: (2015)

Antioxidant Therapy in Cancer: Rationale and Progress
por: Luo, Maochao, et al.
Publicado: (2022)

Mitochondrial adaptation in cancer drug resistance: prevalence, mechanisms, and management
por: Jin, Ping, et al.
Publicado: (2022)

In vitro and in vivo correlation for lipid-based formulations: Current status and future perspectives
por: Huang, Yanping, et al.
Publicado: (2021)

Noncoding RNAs link metabolic reprogramming to immune microenvironment in cancers
por: Zhang, Yiyin, et al.
Publicado: (2021)

Comprehensive landscape and future perspectives of long noncoding RNAs (lncRNAs) in colorectal cancer (CRC): Based on a bibliometric analysis
por: He, Jia, et al.
Publicado: (2022)

Emerging role of tumor cell plasticity in modifying therapeutic response
por: Qin, Siyuan, et al.
Publicado: (2020)

Nanoengineering a metal–organic framework for osteosarcoma chemo-immunotherapy by modulating indoleamine-2,3-dioxygenase and myeloid-derived suppressor cells
por: Fan, Qingxin, et al.
Publicado: (2022)

Managing the immune microenvironment of osteosarcoma: the outlook for osteosarcoma treatment
por: Tian, Hailong, et al.
Publicado: (2023)

Cancer metabolism: current perspectives and future directions
por: Muñoz-Pinedo, C, et al.
Publicado: (2012)

Long-noncoding RNAs (lncRNAs) in drug metabolism and disposition, implications in cancer chemo-resistance
por: Wang, Yue, et al.
Publicado: (2020)

Advances of Long Noncoding RNAs-mediated Regulation in Reproduction
por: Liu, Kang-Sheng, et al.
Publicado: (2018)

Noncoding RNAs
por: Hardikar, Anandwardhan A., et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_om1c0nqdkt49lkum94g0faf1m9